Professor Ke Xu earned his BSc in Microbiology from Nankai University, China, and his Ph.D. in Cell and Molecular Biology from the University of Essex, UK. He completed his postdoctoral training at the Institute of Cancer Research, UK, working on leukemia. Professor Xu carried out his research fellowship at Imperial College London, investigating gene targeting and lung cancer. He joined the Tianjin Lung Cancer Institute of Tianjin Medical University General Hospital, China in 2007 as a principal investigator, studying tumor microenvironment and novel anti-cancer drugs. Professor Xu is an active member of the American Association for Cancer Research, European Association for Cancer Research, the American Society for Cell Biology, and the Chinese Anti-Cancer Association.